Peter Friedmann to Substance Abuse Treatment Centers
This is a "connection" page, showing publications Peter Friedmann has written about Substance Abuse Treatment Centers.
Connection Strength
6.327
-
Andrews CM, Abraham AJ, Grogan CM, Westlake MA, Pollack HA, Friedmann PD. Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health. 2019 03; 109(3):434-436.
Score: 0.598
-
Andrews CM, Grogan CM, Westlake MA, Abraham AJ, Pollack HA, D'Aunno TA, Friedmann PD. Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat. 2018 04; 87:50-55.
Score: 0.559
-
Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017 11 15; 12(1):29.
Score: 0.550
-
D'Aunno T, Pollack H, Chen Q, Friedmann PD. Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey. Med Care. 2017 04; 55(4):379-383.
Score: 0.527
-
Andrews C, Abraham A, Grogan CM, Pollack HA, Bersamira C, Humphreys K, Friedmann P. Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform. Health Aff (Millwood). 2015 May; 34(5):828-35.
Score: 0.461
-
D'Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014 Feb; 49(1):230-48.
Score: 0.408
-
Friedmann PD, Jiang L, Alexander JA. Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programs. J Behav Health Serv Res. 2010 Jul; 37(3):322-37.
Score: 0.302
-
Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2008 Mar; 34(2):165-72.
Score: 0.266
-
Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z. Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs. J Behav Health Serv Res. 2004 Jan-Mar; 31(1):86-97.
Score: 0.210
-
Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res. 2003 Jun; 38(3):887-903.
Score: 0.202
-
Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003 Jan; 18(1):1-8.
Score: 0.196
-
Friedmann PD, Lemon SC, Durkin EM, D'Aunno TA. Trends in comprehensive service availability in outpatient drug abuse treatment. J Subst Abuse Treat. 2003 Jan; 24(1):81-8.
Score: 0.196
-
Friedmann PD, Lemon SC, Stein MD, D'Aunno TA. Community referral sources and entry of treatment-naive clients into outpatient addiction treatment. Am J Drug Alcohol Abuse. 2003; 29(1):105-15.
Score: 0.196
-
Friedmann PD, Lemon SC, Stein MD. Transportation and retention in outpatient drug abuse treatment programs. J Subst Abuse Treat. 2001 Sep; 21(2):97-103.
Score: 0.179
-
Friedmann PD, Lemon SC, Stein MD, Etheridge RM, D'Aunno TA. Linkage to medical services in the Drug Abuse Treatment Outcome Study. Med Care. 2001 Mar; 39(3):284-95.
Score: 0.173
-
Friedmann PD, D'Aunno TA, Jin L, Alexander JA. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res. 2000 Jun; 35(2):443-65.
Score: 0.164
-
Andrews CM, Pollack HA, Abraham AJ, Grogan CM, Bersamira CS, D'Aunno T, Friedmann PD. Medicaid coverage in substance use disorder treatment after the affordable care act. J Subst Abuse Treat. 2019 07; 102:1-7.
Score: 0.152
-
Friedmann PD, Alexander JA, D'Aunno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. J Subst Abuse Treat. 1999 Jan; 16(1):71-80.
Score: 0.149
-
Richter KP, Hunt JJ, Cupertino AP, Gajewski BJ, Jiang Y, Marquis J, Friedmann PD. Commitment and capacity for providing evidence-based tobacco treatment in US drug treatment facilities. Subst Abus. 2017 Jan-Mar; 38(1):35-39.
Score: 0.129
-
Andrews CM, D'Aunno TA, Pollack HA, Friedmann PD. Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs. Med Care Res Rev. 2014 Feb; 71(1):43-60.
Score: 0.103
-
Cupertino AP, Hunt JJ, Gajewski BJ, Jiang Y, Marquis J, Friedmann PD, Engelman KK, Richter KP. The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities. Subst Abuse Treat Prev Policy. 2013 Mar 15; 8:13.
Score: 0.100
-
Hunt JJ, Cupertino AP, Garrett S, Friedmann PD, Richter KP. How is tobacco treatment provided during drug treatment? J Subst Abuse Treat. 2012 Jan; 42(1):4-15.
Score: 0.089
-
Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006 Jan; 44(1):8-15.
Score: 0.060
-
Vassilev ZP, Strauss SM, Astone JM, Friedmann PD, Des Jarlais DC. Provision of on-site medical care to patients with hepatitis C in drug treatment units. J Health Care Poor Underserved. 2004 Nov; 15(4):663-71.
Score: 0.056
-
Kertesz SG, Horton NJ, Friedmann PD, Saitz R, Samet JH. Slowing the revolving door: stabilization programs reduce homeless persons' substance use after detoxification. J Subst Abuse Treat. 2003 Apr; 24(3):197-207.
Score: 0.050
-
Lubelczyk RA, Friedmann PD, Lemon SC, Stein MD, Gerstein DR. HIV prevention services in correctional drug treatment programs: do they change risk behaviors? AIDS Educ Prev. 2002 Apr; 14(2):117-25.
Score: 0.047
-
Stein MD, Anderson B, Charuvastra A, Maksad J, Friedmann PD. A brief intervention for hazardous drinkers in a needle exchange program. J Subst Abuse Treat. 2002 Jan; 22(1):23-31.
Score: 0.046
-
Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001 Sep 01; 64(1):47-53.
Score: 0.045
-
Orr MF, Glebatis D, Friedmann P, des Jarlais DC, Prevots DR. Incidence of HIV infection in a New York City methadone maintenance treatment program. JAMA. 1996 Jul 10; 276(2):99.
Score: 0.031
-
Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991 Sep; 81(9):1185-91.
Score: 0.022
-
Sacks S, Cleland CM, Melnick G, Flynn PM, Knight K, Friedmann PD, Prendergast ML, Coen C. Violent offenses associated with co-occurring substance use and mental health problems: evidence from CJDATS. Behav Sci Law. 2009 Jan-Feb; 27(1):51-69.
Score: 0.019
-
Gordon AJ, Fiellin DA, Friedmann PD, Gourevitch MN, Kraemer KL, Arnsten JH, Saitz R. Update in addiction medicine for the primary care clinician. J Gen Intern Med. 2008 Dec; 23(12):2112-6.
Score: 0.018
-
Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addict Behav. 2003 Sep; 28(7):1323-31.
Score: 0.013
-
Charuvastra A, Anderson BJ, Friedmann PD, Stein MD. Perceived addiction treatment needs among alcohol using injection drug users. J Addict Dis. 2002; 21(4):93-107.
Score: 0.011